| Symbol | TVGN |
|---|---|
| Name | TEVOGEN BIO HOLDINGS INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 15 INDEPENDENCE BOULEVARD,SUITE #210, WARREN, New Jersey, 07059, United States |
| Telephone | +1 877 - 838-6436 |
| Fax | — |
| — | |
| Website | https://www.tevogen.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001860871 |
| Description | Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Additional info from NASDAQ: |
(99% Neutral) TEVOGEN BIO HOLDINGS INC. (TVGN) Announces Executive Changes
Read moreNew Form S-8 - Tevogen Inc. <b>Filed:</b> 2026-08-24 <b>AccNo:</b> 0001493152-26-039922 <b>Size:</b> 251 KB
Read more(99% Neutral) TEVOGEN BIO HOLDINGS INC. (TVGN) Announces Executive Changes
Read moreTVGNW attributes changed: Attr: Sec_name Tevogen Bio Holdings Inc. - Warrant -> Tevogen Inc. - Warrant;
Read moreNew Form PRE 14A - Tevogen Bio Holdings Inc. <b>Filed:</b> 2026-07-23 <b>AccNo:</b> 0001493152-26-034442 <b>Size:</b> 3 MB
Read moreNew Form 424B3 - Tevogen Bio Holdings Inc. <b>Filed:</b> 2026-06-26 <b>AccNo:</b> 0001493152-26-030238 <b>Size:</b> 171 KB
Read moreNew Form S-3 - Tevogen Bio Holdings Inc. <b>Filed:</b> 2026-06-12 <b>AccNo:</b> 0001493152-26-028495 <b>Size:</b> 458 KB
Read moreTevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
Read more